Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
Yeshwanter Radhakrishnan, Parikshit Duriseti, Fouad T. Chebib
Kidney Res Clin Pract. 2022;41(4):422-431.   Published online 2022 Mar 29     DOI: https://doi.org/10.23876/j.krcp.21.309
Citations to this article as recorded by Crossref logo
Outcomes from the Northeast England cohort of autosomal dominant polycystic kidney disease (ADPKD) patients on tolvaptan
Eleftherios Gkekas, Tsz Yau Tiffany Tang, Alan Green, Han Davidson, Rachel Fraser, John A. Sayer, Shalabh Srivastava
Frontiers in Nephrology.2022;[Epub]     CrossRef